Literature DB >> 15781653

Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

Olga Berezovskaya1, Aaron D Schimmer, Anna B Glinskii, Clemencia Pinilla, Robert M Hoffman, John C Reed, Gennadi V Glinsky.   

Abstract

Survival in lymph or blood is an essential prerequisite for metastasis of carcinoma cells to distant organs. Recently, we reported isolation and initial biological characterization of circulating metastatic cells in a fluorescent, orthotopic, metastatic nude-mouse model of human prostate cancer. Here we show that the metastatic human prostate carcinoma cells selected for survival in the circulation have increased resistance to anoikis, which is apoptosis induced by cell detachment. Using gene silencing and gene transfer techniques, we show that increased expression of the apoptosis inhibitory protein XIAP contributes to anoikis resistance of the circulating metastatic human prostate carcinoma cells. We also provide initial preclinical data on the antimetastatic efficacy of recently discovered small-molecule antagonists of XIAP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781653     DOI: 10.1158/0008-5472.CAN-04-2649

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  85 in total

1.  Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.

Authors:  Kozue Sakao; Sudhakar Desineni; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

Review 2.  Induction of apoptosis in lymphoid and myeloid leukemia.

Authors:  Aaron D Schimmer
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

3.  The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.

Authors:  Harriet M Kluger; Mary M McCarthy; Ayesha B Alvero; Mario Sznol; Stephan Ariyan; Robert L Camp; David L Rimm; Gil Mor
Journal:  J Transl Med       Date:  2007-01-26       Impact factor: 5.531

4.  Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis.

Authors:  Kirk Jensen; Aneeta Patel; Joanna Klubo-Gwiezdzinska; Andrew Bauer; Vasyl Vasko
Journal:  Endocr Relat Cancer       Date:  2011-09-20       Impact factor: 5.678

5.  Cytotoxic Tumor-Targeting Peptides From In Vivo Phage Display.

Authors:  Jessica R Newton Northup; Susan L Deutscher
Journal:  Comb Chem High Throughput Screen       Date:  2016       Impact factor: 1.339

6.  ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.

Authors:  I A Khan; B H Yoo; O Masson; S Baron; D Corkery; G Dellaire; L D Attardi; K V Rosen
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

7.  Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo.

Authors:  Mathieu Derouet; Xue Wu; Linda May; Byong Hoon Yoo; Takehiko Sasazuki; Senji Shirasawa; Janusz Rak; Kirill V Rosen
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment.

Authors:  Lubing Gu; Hailong Zhang; Tao Liu; Sheng Zhou; Yuhong Du; Jing Xiong; Sha Yi; Cheng-Kui Qu; Haian Fu; Muxiang Zhou
Journal:  Cancer Cell       Date:  2016-09-22       Impact factor: 31.743

9.  Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells.

Authors:  Byong Hoon Yoo; Xue Wu; Yongling Li; Mehnaaz Haniff; Takehiko Sasazuki; Senji Shirasawa; Eeva-Liisa Eskelinen; Kirill V Rosen
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

10.  Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

Authors:  Edward W Howard; Steve C L Leung; H F Yuen; Chee Wai Chua; Davy T Lee; K W Chan; Xianghong Wang; Yong Chuan Wong
Journal:  Clin Exp Metastasis       Date:  2008-03-14       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.